Editorial Board

Honorary Editor-in-Chief
Prof Yi-Xin Zeng, Peking Union Medical College, China

Editor-in-Chief
Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Associate Editors
Prof Chao-Nan Qian, Sun Yat-sen University Cancer Center, China
Prof Wei Zhang, University of Texas MD Anderson Cancer Center, USA

Editorial Board
Prof Carlos Arteaga, Vanderbilt University, USA
Prof Sujuan Ba, National Foundation for Cancer Research, USA 
Prof Mikhail V. Blagosklonny, Roswell Park Cancer Institute, USA    
Prof Yihai Cao, Krolinska Institute, Sweden
Prof Webster Cavenee, University of California at San Diego, USA
Prof Anthony T.C. Chan, The Chinese University of Hong Kong, China
Prof Ke-Xin Chen, Tianjin Medical University, China
Prof Wan-Qing Chen, Peking Union Medical College, China
Prof Zhe-Sheng Chen, St. John's University, USA
Prof Shi-Yuan Cheng, University of Pittsburgh Cancer Institute, USA
Prof Laurence Cooper, University of Texas MD Anderson Cancer Center, USA 
Prof Ingemar Ernberg, Karolinska Institute, Sweden 
Prof Jianhua Fu, Sun Yat-sen University Cancer Center, China
Prof Li-Wu Fu, Sun Yat-sen University Cancer Center, China
Prof Gregory Fuller, University of Texas MD Anderson Cancer Center, USA
Prof Sharlene Gill, BC Cancer Agency Vancouver, Canada
Prof Jie He, Chinese Academy of Medical Sciences, China 
Prof Carl-Henrik Heldin, Uppsala University, Sweden 
Prof Peng Huang, University of Texas MD Anderson Cancer Center, USA
Prof Wen-Lin Huang, Sun Yat-sen University Cancer Center, China 
Prof Guido Kroemer, INSERM, France
Prof Shengping Li, Sun Yat-sen Univeristy Cancer Center, China
Prof Ye-Xiong Li, Peking Union Medical College, China
Prof Dongxin Lin, Chinese Academy of Medical Sciences, China
Prof Quertin Liu, Sun Yat-sen University Cancer Center, China
Prof Zhi-Hua Liu, Peking Union Medical College, China
Prof Kwok Wai Lo, The Chinese University of Hong Kong, China
Prof Zhi-Min Lu, University of Texas MD Anderson Cancer Center, USA
Prof Jun Ma, Sun Yat-sen University Cancer Center, China
Prof Jeffrey P MacKeigan, Van Andel Research Institute, USA 
Prof Gerry Melino, University of Rome, Italy
Prof Delia Mezzanzanica, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Prof Rene-Olivier Mirimanoff, University of Lausanne Medical Center, Switzerland
Prof Boris Pasche, Comprehensive Cancer Center of Wake Forest University, USA
Prof You-Lin Qiao, Peking Union Medical College, China
Prof Neal NR Rosen, Memorial Sloan-Kettering Cancer Center, USA
Prof Keng Shen, Peking Union Medical College, China
Prof Ilya Shmulevich, Institute for Systems Biology, USA
Prof Erwei Song, Sun Yat-sen Memorial Hospital, China
Prof Anil K Sood, University of Texas MD Anderson Cancer Center, USA
Prof Qian Tao, The Chinese University of Hong Kong, China
Prof Yunguang Tong, UCLA School of Medicine, USA
Prof Joseph Wee, National Cancer Center, Singapore
Prof Xiao-Ming Xie, Sun Yat-sen University Cancer Center, China 
Prof Xiang-Xi (Mike) Xu, Sylvester Comprehensive Cancer Center, USA    
Prof Li Yan, GlaxoSmithKline PLC, USA
Prof Olli Yli-Harja, Tampere University of Technology, Finland
Prof Lawrence Young, University of Birmingham, UK
Prof Dihua Yu, University of Texas MD Anderson Cancer Center, USA
Prof Yun-Fei Yuan, Sun Yat-Sen University Cancer Center, China
Prof Mu-Sheng Zeng, Sun Yat-Sen University Cancer Center, China
Prof Jian Zhang, Guangxi Medical University, China
Prof Li Zhang, Sun Yat-sen University Cancer Center, China
Prof Ming Zhou, Glickman Urological Institute, USA 
Prof Wei-Ping Zhou, University of Michigan, USA    
Prof Zhi-Wei Zhou, Sun Yat-sen University Cancer Center, China
Prof Xiao-Feng Zhu, Sun Yat-sen University Cancer Center, China

Society Affiliations

 

Chinese Journal of Cancer is affiliated to the Chinese Anti-Cancer Association and the US Chinese Anti-Cancer Association.

                       ​​​​​​​

Advertisement